GLP-1 receptor agonists, originally introduced in 2006, have undergone significant advancements over the years. David Ricks, ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...

MAGA Gov. Glenn Youngkin has, for a second straight year, vetoed legislation that would establish a Prescription Drug ...

The business-software group claimed the top spot as Europe’s largest company by market value, dethroning Wegovy maker Novo ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Australia’s peak medicines industry group says it takes 466 days for approved medicines to become subsidised. Health Minister ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or "the Company"), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results ...

As evident, Hazlitt’s one lesson has vast applications. This essay now delves into its deployment on the Danish welfare state ...

Australians with chronic conditions could save more than $80 a year as plans to cut prescription medicine costs receive ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...